妇炎康复胶囊联合甲硝唑治疗慢性盆腔炎的临床疗效观察

Observation of Clinical Effect on Chronic Pelvic Inflammatory Disease Treated with Fuyankang Capsule Combined With Metronidazole

目的:探讨妇炎康复胶囊联合甲硝唑治疗慢性盆腔炎的临床疗效及安全性。方法:选取86例慢性盆腔炎患者,随机分为对照组和治疗组,两组在常规治疗的基础上,均静脉滴注甲硝唑氯化钠注射液,治疗组在此基础上,加用妇炎康复胶囊,连续治疗3个疗程,观察临床疗效及安全性。结果:两组患者经治疗后,临床症状及体征均明显改善,其中对照组总有效率为79.1%,治疗组总有效率为95.3%,治疗组总有效率明显优于对照组,有显著性差异(P<0.05);输卵管造影,治疗组的正常率为81.4%,对照组的正常率为67.4%,具有显著性差异(P<0.05);两组均未出现严重的不良反应。结论:妇炎康复胶囊联合甲硝唑用于治疗慢性盆腔炎,具有安全、有效、可靠等特点,为临床治疗慢性盆腔炎提供了一种较好的方法,具有一定的临床借鉴意义。

Objective ： To explore the clinical efficacy and safety of Fuyankang Capsule combined with metronidazole in the treatment of chronic pelvic inflammatory disease. Method： 86 cases of chronic pelvic inflammatory disease were randomly divided into control and treatment groups. The two groups were given conventional treatment and both intravenous metronidazole sodium chloride injection. The treatment group added Fuyankang Capsules,continuously for 3 courses. The clinical efficacy and safety were observed. Results ： After treatment, clinical symptoms and signs in two groups were significantly improved. The total effective rate was 79.1% in the control group and total effective rate was 95.3% in the treatment group with a significant difference （P 〈0.05）. HSG normal rate of the treatment group was 81.4% and that of the normal control group was 67.4% with a significant difference （ P 〈 0.05）. There were no severe adverse reactions in two groups. Conclusion： Fuyankang capsules combined with metronidazole for the treatment of chronic pelvic inflammatory disease is safe, effective and reliable with certain clinical reference.